ONC
BeiGene, Ltd.
NASDAQ: ONC · HEALTHCARE · BIOTECHNOLOGY
$295.27
+1.54% today
Updated 2026-04-30
Market cap
$33.18B
P/E ratio
120.52
P/S ratio
6.21x
EPS (TTM)
$2.48
Dividend yield
—
52W range
$218 – $385
Volume
0.2M
BeiGene, Ltd. (ONC) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.15M | $13.04M | $8.82M | $1.07M | $238.39M | $198.22M | $428.21M | $308.87M | $1.18B | $1.42B | $2.46B | $3.81B | $5.34B |
| Revenue growth (YoY) | — | +16.9% | -32.4% | -87.9% | +22179.2% | -16.8% | +116.0% | -27.9% | +280.8% | +20.4% | +73.7% | +55.0% | +40.2% |
| Cost of revenue | $13.46M | $21.86M | $58.25M | $98.03M | $273.99M | $707.71M | $71.19M | $70.66M | $164.91M | $286.48M | $379.92M | $594.09M | $668.54M |
| Gross profit | $-2.31M | $-8.83M | $-49.43M | $-96.96M | $-35.60M | $-509.49M | $357.02M | $238.22M | $1.01B | $1.13B | $2.08B | $3.22B | $4.67B |
| Gross margin | -20.8% | -67.7% | -560.7% | -9062.0% | -14.9% | -257.0% | 83.4% | 77.1% | 86.0% | 79.8% | 84.5% | 84.4% | 87.5% |
| R&D | $13.46M | $21.86M | $58.25M | $98.03M | $269.02M | $679.00M | $927.34M | $1.29B | $1.46B | $1.64B | $1.78B | $1.95B | $2.15B |
| SG&A | $3.14M | $6.93M | $7.31M | $20.10M | $62.60M | $195.38M | — | $600.18M | $990.12M | $1.28B | $1.51B | $1.83B | $2.08B |
| Operating income | $-5.46M | $-15.76M | $-56.74M | $-117.06M | $-98.46M | $-705.77M | $-959.89M | $-1.66B | $-1.44B | $-1.79B | $-1.21B | $-568.20M | $447.14M |
| Operating margin | -49.0% | -120.9% | -643.7% | -10940.2% | -41.3% | -356.1% | -224.2% | -536.7% | -122.3% | -126.4% | -49.1% | -14.9% | 8.4% |
| EBITDA | $-3.15M | $-14.20M | $-55.20M | $-115.15M | $-93.70M | $-695.38M | $-941.27M | $-1.63B | $-1.39B | $-1.72B | $-1.12B | $-396.44M | $616.77M |
| EBITDA margin | -28.2% | -108.9% | -626.1% | -10761.8% | -39.3% | -350.8% | -219.8% | -526.4% | -118.4% | -121.7% | -45.6% | -10.4% | 11.5% |
| EBIT | $-4.74M | $-15.76M | $-56.74M | $-117.06M | $-98.46M | $-705.77M | $-959.89M | $-1.66B | $-1.44B | $-1.79B | $-1.21B | $-568.20M | $475.09M |
| Interest expense | $3.15M | $3.55M | $1.23M | $383000.00 | $4.11M | $13.95M | — | — | — | $52.48M | $4.36M | $21.80M | $58.23M |
| Income tax | $3.34M | $3.88M | $-2.10M | $54000.00 | $2.23M | $-15.80M | $6.99M | $10.40M | $19.23M | $42.78M | $55.87M | $111.78M | — |
| Effective tax rate | -80.4% | -27.0% | 3.6% | -0.0% | -2.5% | 2.3% | -0.7% | -0.6% | -1.3% | -2.2% | -6.8% | -21.0% | 0.0% |
| Net income | $-7.49M | $-18.28M | $-57.10M | $-119.22M | $-93.11M | $-673.77M | $-948.63M | $-1.62B | $-1.46B | $-2.00B | $-881.71M | $-644.79M | $286.93M |
| Net income growth (YoY) | — | -143.9% | -212.4% | -108.8% | +21.9% | -623.7% | -40.8% | -71.3% | +10.3% | -37.5% | +56.0% | +26.9% | +144.5% |
| Profit margin | -67.2% | -140.2% | -647.7% | -11141.8% | -39.1% | -339.9% | -221.5% | -526.1% | -123.9% | -141.5% | -35.9% | -16.9% | 5.4% |